Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-042910
Filing Date
2020-07-17
Accepted
2020-07-17 17:23:38
Documents
1
Period of Report
2020-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7572
  Complete submission text file 0001209191-20-042910.txt   8935
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Issuer) CIK: 0001080709 (see all company filings)

EIN.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARENA PHARMACEUTICALS, INC. 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address
Cabell Christopher (Reporting) CIK: 0001814928 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-31161 | Film No.: 201034450